TCTN1

gene
On this page

Also known as FLJ21127TECT1JBTS13

Summary

TCTN1 (tectonic family member 1, HGNC:26113) is a protein-coding gene on chromosome 12q24.11, encoding Tectonic-1 (Q2MV58). Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes.

This gene encodes a member of a family of secreted and transmembrane proteins. The orthologous gene in mouse functions downstream of smoothened and rab23 to modulate hedgehog signal transduction. This protein is a component of the tectonic-like complex, which forms a barrier between the ciliary axoneme and the basal body. A mutation in this gene was found in a family with Joubert syndrome-13. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 79600 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): Joubert syndrome 13 (Strong, GenCC) — +2 more curated relationships
  • GWAS associations: 2
  • Clinical variants (ClinVar): 505 total — 33 pathogenic, 29 likely-pathogenic
  • Phenotypes (HPO): 80
  • Dosage sensitivity (ClinGen): haploinsufficiency autosomal recessive, triplosensitivity no evidence
  • MANE Select transcript: NM_001082538

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26113
Approved symbolTCTN1
Nametectonic family member 1
Location12q24.11
Locus typegene with protein product
StatusApproved
AliasesFLJ21127, TECT1, JBTS13
Ensembl geneENSG00000204852
Ensembl biotypeprotein_coding
OMIM609863
Entrez79600

Gene structure

Transcript identifiers

Ensembl transcripts: 81 — 44 protein_coding, 23 nonsense_mediated_decay, 13 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000377654, ENST00000397655, ENST00000397656, ENST00000397659, ENST00000460357, ENST00000463313, ENST00000464809, ENST00000471804, ENST00000478122, ENST00000480648, ENST00000481093, ENST00000481720, ENST00000482281, ENST00000485445, ENST00000490514, ENST00000491068, ENST00000495659, ENST00000498072, ENST00000546643, ENST00000547461, ENST00000547868, ENST00000549123, ENST00000550703, ENST00000551555, ENST00000551590, ENST00000552038, ENST00000552318, ENST00000552762, ENST00000614115, ENST00000679401, ENST00000679473, ENST00000679617, ENST00000679713, ENST00000680068, ENST00000680168, ENST00000680203, ENST00000680445, ENST00000680512, ENST00000680548, ENST00000680571, ENST00000681395, ENST00000681437, ENST00000681604, ENST00000681703, ENST00000681740, ENST00000681807, ENST00000681851, ENST00000889000, ENST00000889001, ENST00000889002, ENST00000889003, ENST00000889004, ENST00000889005, ENST00000889006, ENST00000889007, ENST00000889008, ENST00000889009, ENST00000889010, ENST00000889011, ENST00000889012, ENST00000889013, ENST00000889014, ENST00000889015, ENST00000889016, ENST00000889017, ENST00000889018, ENST00000889019, ENST00000889020, ENST00000889021, ENST00000889022, ENST00000934350, ENST00000949050, ENST00000949051, ENST00000949052, ENST00000949053, ENST00000949054, ENST00000949055, ENST00000949056, ENST00000949057, ENST00000949058, ENST00000949059

RefSeq mRNA: 8 — MANE Select: NM_001082538 NM_001082537, NM_001082538, NM_001173975, NM_001173976, NM_001319680, NM_001319681, NM_001319682, NM_024549

CCDS: CCDS41833, CCDS41834, CCDS41835, CCDS91749

Canonical transcript exons

ENST00000397659 — 15 exons

ExonStartEnd
ENSE00001829401110614129110614402
ENSE00002378299110649043110649430
ENSE00003462778110636481110636501
ENSE00003463221110640383110640517
ENSE00003506109110632472110632559
ENSE00003546987110647749110647893
ENSE00003549201110641542110641627
ENSE00003553288110641024110641149
ENSE00003592438110644967110645129
ENSE00003635688110647196110647336
ENSE00003659257110634670110634779
ENSE00003661350110619836110619956
ENSE00003686984110642249110642389
ENSE00003689626110626362110626492
ENSE00003743415110628767110628918

Expression profiles

Bgee: expression breadth ubiquitous, 230 present calls, max score 98.58.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.2924 / max 333.3522, expressed in 1775 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
12800422.15861772
1280031.0897731
1280051.0440635

Top tissues by expression

268 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130298.58gold quality
adenohypophysisUBERON:000219696.56gold quality
olfactory segment of nasal mucosaUBERON:000538695.32gold quality
pituitary glandUBERON:000000795.28gold quality
ventricular zoneUBERON:000305395.02gold quality
right lobe of thyroid glandUBERON:000111995.00gold quality
left lobe of thyroid glandUBERON:000112094.94gold quality
bronchial epithelial cellCL:000232894.76gold quality
right testisUBERON:000453494.73gold quality
thyroid glandUBERON:000204694.44gold quality
left testisUBERON:000453394.19gold quality
epithelium of bronchusUBERON:000203193.88gold quality
right ovaryUBERON:000211893.58gold quality
left ovaryUBERON:000211993.42gold quality
bronchusUBERON:000218593.04gold quality
stromal cell of endometriumCL:000225592.40gold quality
metanephros cortexUBERON:001053392.32gold quality
endocervixUBERON:000045891.90gold quality
testisUBERON:000047391.89gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099191.74gold quality
right adrenal gland cortexUBERON:003582791.66gold quality
body of uterusUBERON:000985391.54gold quality
gall bladderUBERON:000211091.52gold quality
right coronary arteryUBERON:000162591.42gold quality
right atrium auricular regionUBERON:000663191.24gold quality
right adrenal glandUBERON:000123391.22gold quality
left adrenal gland cortexUBERON:003582591.10gold quality
ovaryUBERON:000099291.06gold quality
left uterine tubeUBERON:000130390.88gold quality
left adrenal glandUBERON:000123490.64gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-114yes10.76
E-ANND-3yes7.38
E-GEOD-86618no48.86

Regulation

Is transcription factor: no

Functional genomics

ClinGen dosage: haploinsufficiency 30 (autosomal recessive), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map

Literature-anchored findings (GeneRIF, showing 9)

  • Mutations in Tctn1 is associated with ciliopathies. (PMID:21725307)
  • TCTN1 may serve as a novel prognostic factor and a potential therapeutic target for glioblastoma. (PMID:25304031)
  • These data suggest TCTN1 is essential for glioma cell viability, and dysregulation of TCTN1 may play a key role in glioma tumorigenesis. (PMID:25737023)
  • These findings confirmed the direct association between the TCTN1 gene and prostate cancer growth in vitro. (PMID:26310786)
  • Flow cytometry analysis showed that depletion of TCTN1 could cause cell cycle arrest at the G2/M phase. This indicates that TCTN1 may be crucial for CRC cell growth. (PMID:28123172)
  • we describe the phenotype of a patient with Varadi syndrome who is homozygous for a previously reported mutation in TCTN1 (NM_001082538.2:c.342-2A>G, p.Gly115Lysfs*8) and suggest that allelic disorders linked to TCTN1 include Varadi syndrome, in addition to Joubert syndrome and Meckel-Gruber syndrome. (PMID:28631893)
  • Two novel TCTN1 mutations were identified in a family with Joubert syndrome (PMID:31302911)
  • microRNA-216a-5p inhibits the development of gastric cancer through target combination with TCTN1. (PMID:32486612)
  • Function and transcriptional regulation of TCTN1 in oral squamous cell carcinoma. (PMID:34859261)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotctn1ENSDARG00000078447
mus_musculusTctn1ENSMUSG00000038593
rattus_norvegicusTctn1ENSRNOG00000028523
caenorhabditis_elegansWBGENE00017120

Paralogs (2): TCTN3 (ENSG00000119977), TCTN2 (ENSG00000168778)

Protein

Protein identifiers

Tectonic-1Q2MV58 (reviewed: Q2MV58)

All UniProt accessions (19): A0A087X1J4, A0A0A0MRU7, A0A7P0T8M6, A0A7P0T8R0, A0A7P0T9A6, A0A7P0TA68, A0A7P0TAW1, B4DIB9, E9PIB8, E9PNE4, E9PR69, Q2MV58, F8VQ12, F8VSB8, J3KPW2, S4R2Y1, S4R339, S4R3G2, S4R3M8

UniProt curated annotations — full annotation on UniProt →

Function. Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Regulator of Hedgehog (Hh), required for both activation and inhibition of the Hh pathway in the patterning of the neural tube. During neural tube development, it is required for formation of the most ventral cell types and for full Hh pathway activation. Functions in Hh signal transduction to fully activate the pathway in the presence of high Hh levels and to repress the pathway in the absence of Hh signals. Modulates Hh signal transduction downstream of SMO and RAB23.

Subunit / interactions. Part of the tectonic-like complex (also named B9 complex).

Subcellular location. Cytoplasm. Cytoskeleton. Cilium basal body. Secreted.

Disease relevance. Joubert syndrome 13 (JBTS13) [MIM:614173] A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. The disease is caused by variants affecting the gene represented in this entry.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the tectonic family.

Isoforms (6)

UniProt IDNamesCanonical?
Q2MV58-11yes
Q2MV58-22
Q2MV58-33
Q2MV58-44
Q2MV58-55
Q2MV58-66

RefSeq proteins (8): NP_001076006, NP_001076007, NP_001167446, NP_001167447, NP_001306609, NP_001306610, NP_001306611, NP_078825 (=MANE)

Domains & families (InterPro)

IDNameType
IPR011677TCTN1-3_domDomain
IPR040354TCTN1-3Family
IPR057724TCTN1-3_NDomain

Pfam: PF07773, PF25752

UniProt features (18 total): splice variant 8, sequence conflict 3, glycosylation site 3, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q2MV58-F178.100.37

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (3): 36, 295, 528

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-5620912Anchoring of the basal body to the plasma membrane
R-HSA-1852241Organelle biogenesis and maintenance
R-HSA-5617833Cilium Assembly

MSigDB gene sets: 310 (showing top): GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_PROTEIN_LOCALIZATION_TO_CILIUM, GOBP_NEUROGENESIS, GOBP_NEURAL_TUBE_DEVELOPMENT, GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM, GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD, GOBP_DORSAL_VENTRAL_PATTERN_FORMATION, GOBP_FOREBRAIN_DEVELOPMENT, GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION, GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT, MODULE_205, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT

GO Biological Process (10): in utero embryonic development (GO:0001701), neural tube formation (GO:0001841), regulation of smoothened signaling pathway (GO:0008589), somatic motor neuron differentiation (GO:0021523), telencephalon development (GO:0021537), dorsal/ventral neural tube patterning (GO:0021904), central nervous system interneuron axonogenesis (GO:0021956), cilium assembly (GO:0060271), protein localization to ciliary transition zone (GO:1904491), cell projection organization (GO:0030030)

GO Molecular Function (0):

GO Cellular Component (9): obsolete extracellular space (GO:0005615), cytosol (GO:0005829), membrane (GO:0016020), MKS complex (GO:0036038), extracellular region (GO:0005576), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), ciliary transition zone (GO:0035869), cell projection (GO:0042995)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Assembly of the 9+0 primary cilium1
Organelle biogenesis and maintenance1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure6
protein localization to cilium2
chordate embryonic development1
embryonic epithelial tube formation1
neural tube development1
smoothened signaling pathway1
regulation of signal transduction1
spinal cord motor neuron differentiation1
forebrain development1
anatomical structure development1
dorsal/ventral pattern formation1
neural tube patterning1
central nervous system neuron axonogenesis1
axoneme assembly1
intraciliary transport involved in cilium assembly1
cilium organization1
organelle assembly1
trans-Golgi to periciliary membrane compartment transport1
plasma membrane bounded cell projection assembly1
ciliary transition zone assembly1
cellular component organization1
cytoplasm1
protein-containing complex1
ciliary transition zone1
intracellular anatomical structure1
intracellular membraneless organelle1
cilium1

Protein interactions and networks

STRING

744 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TCTN1B9D1Q9UPM9991
TCTN1MKS1Q9NXB0987
TCTN1CC2D2AQ9P2K1981
TCTN1TMEM216Q9P0N5976
TCTN1TCTN2Q96GX1975
TCTN1TMEM67Q5HYA8968
TCTN1TMEM231Q9H6L2964
TCTN1TCTN3Q6NUS6960
TCTN1B9D2Q9BPU9953
TCTN1CEP290O15078946
TCTN1AHI1Q8N157896
TCTN1TMEM237Q96Q45862
TCTN1NPHP1O15259830
TCTN1TMEM17Q86X19823
TCTN1RPGRIP1LQ68CZ1803

IntAct

28 interactions, top by confidence:

ABTypeScore
TMEM231TCTN1psi-mi:“MI:0914”(association)0.640
KNG1CTSVpsi-mi:“MI:0914”(association)0.530
SLC15A4PGRMC1psi-mi:“MI:0914”(association)0.530
CDH23GTPBP10psi-mi:“MI:0914”(association)0.350
PSCAMETTL15psi-mi:“MI:0914”(association)0.350
GPIHBP1SAC3D1psi-mi:“MI:0914”(association)0.350
CST9LQSOX1psi-mi:“MI:0914”(association)0.350
NMSMANBApsi-mi:“MI:0914”(association)0.350
TMEM25NME4psi-mi:“MI:0914”(association)0.350
TMEM231TNFRSF10Bpsi-mi:“MI:0914”(association)0.350
CD160PLXNB2psi-mi:“MI:0914”(association)0.350
IDSCOCHpsi-mi:“MI:0914”(association)0.350
DEFB109BCHST10psi-mi:“MI:0914”(association)0.350
EDDM3APLXNA2psi-mi:“MI:0914”(association)0.350
LCN9C1QL1psi-mi:“MI:0914”(association)0.350
B9D2PARNpsi-mi:“MI:0914”(association)0.350
TCTN1NPTX1psi-mi:“MI:0914”(association)0.350
EDN3POTEFpsi-mi:“MI:0914”(association)0.350
CST11PLXNB2psi-mi:“MI:0914”(association)0.350
TCTN1GUSBpsi-mi:“MI:0914”(association)0.350
TCTN1TOR1Apsi-mi:“MI:2364”(proximity)0.270
TCTN1PLOD2psi-mi:“MI:2364”(proximity)0.270
TCTN3TCTN1psi-mi:“MI:0915”(physical association)0.000
TCTN2TCTN1psi-mi:“MI:0915”(physical association)0.000
TMEM231TCTN1psi-mi:“MI:0915”(physical association)0.000

BioGRID (173): TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), ASPH (Proximity Label-MS), BCAP31 (Proximity Label-MS), BRI3BP (Proximity Label-MS), CALR (Proximity Label-MS), CALU (Proximity Label-MS), CANX (Proximity Label-MS), CCDC134 (Proximity Label-MS), CKAP4 (Proximity Label-MS), CNPY2 (Proximity Label-MS), CNPY3 (Proximity Label-MS)

ESM2 similar proteins: A2A6C4, A4D0V7, A4FV27, A6QQ85, A7VL23, A8MWV9, B0FP48, D4A6L0, E1BBQ2, E5RIL1, O54715, O73698, O75129, O75631, O76095, P0C8N6, P38574, P40682, Q14C87, Q14DG7, Q15904, Q2MV58, Q3UN70, Q3ZBK7, Q52LC2, Q5PPI4, Q5T848, Q5ZJY9, Q60943, Q61137, Q6PGD0, Q76HP2, Q76HP3, Q80YF6, Q80Z10, Q864V4, Q8BZ64, Q8C419, Q8CB65, Q8CEF9

Diamond homologs: Q2MV58, Q4R9E0, Q6NUS6, Q8BZ64, Q8R2Q6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

505 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic33
Likely pathogenic29
Uncertain significance183
Likely benign196
Benign23

Top pathogenic / likely-pathogenic (30)

Variant IDHGVSClassification
1033279NM_001082538.3(TCTN1):c.26_29dup (p.Val11fs)Pathogenic
1252090NM_001082538.3(TCTN1):c.1385dup (p.Trp463fs)Pathogenic
1374749NM_001082538.3(TCTN1):c.156del (p.Arg52fs)Pathogenic
1374980NM_001082538.3(TCTN1):c.1465del (p.His489fs)Pathogenic
1406500NM_001082538.3(TCTN1):c.1527del (p.Ala511fs)Pathogenic
1410963NM_001082538.3(TCTN1):c.736A>T (p.Lys246Ter)Pathogenic
1454973NM_001082538.3(TCTN1):c.1775_1778del (p.Val592fs)Pathogenic
1455274NC_000012.11:g.(?111064147)(111064317_?)delPathogenic
1805072NM_001082538.3(TCTN1):c.378_381dup (p.Ser128fs)Pathogenic
183312NM_001082538.3(TCTN1):c.342-2A>GPathogenic
1903848NM_001082538.3(TCTN1):c.822+1G>APathogenic
2000289NM_001082538.3(TCTN1):c.210dup (p.Val71fs)Pathogenic
212386NM_001082538.3(TCTN1):c.843+1delPathogenic
221983NM_001082538.3(TCTN1):c.898C>T (p.Arg300Ter)Pathogenic
2423665NC_000012.11:g.(?111064147)(111074326_?)delPathogenic
2921929NM_001082538.3(TCTN1):c.256_257del (p.Gln86fs)Pathogenic
2939936NM_001082538.3(TCTN1):c.209_210del (p.Pro70fs)Pathogenic
2942895NM_001082538.3(TCTN1):c.962del (p.Val321fs)Pathogenic
2948555NM_001082538.3(TCTN1):c.1505dup (p.Leu502fs)Pathogenic
30803NM_001082538.3(TCTN1):c.221-2A>GPathogenic
3244265NC_000012.11:g.(?111057621)(111057781_?)delPathogenic
3366343NM_001082538.3(TCTN1):c.291C>A (p.Cys97Ter)Pathogenic
3366636NM_001082538.3(TCTN1):c.1114dup (p.Gln372fs)Pathogenic
3752289NM_001082538.3(TCTN1):c.514G>T (p.Glu172Ter)Pathogenic
4277234NM_001082538.3(TCTN1):c.342-2A>CPathogenic
4784183NM_001082538.3(TCTN1):c.1159_1160dup (p.Leu388fs)Pathogenic
4793524NM_001082538.3(TCTN1):c.256C>T (p.Gln86Ter)Pathogenic
4848272NM_001082538.3(TCTN1):c.1133del (p.Gly378fs)Pathogenic
829835NM_001082538.3(TCTN1):c.1454G>A (p.Trp485Ter)Pathogenic
833489NC_000012.12:g.(?110626342)(110642409_?)delPathogenic

SpliceAI

3540 predictions. Top by Δscore:

VariantEffectΔscore
12:110619834:A:AGacceptor_gain1.0000
12:110619835:G:GGacceptor_gain1.0000
12:110619952:GTCAC:Gdonor_gain1.0000
12:110619957:G:GGdonor_gain1.0000
12:110626360:A:AGacceptor_gain1.0000
12:110626360:AG:Aacceptor_gain1.0000
12:110626360:AGG:Aacceptor_gain1.0000
12:110626361:G:GGacceptor_gain1.0000
12:110626361:GG:Gacceptor_gain1.0000
12:110626361:GGG:Gacceptor_gain1.0000
12:110626361:GGGGC:Gacceptor_gain1.0000
12:110626488:AAACT:Adonor_gain1.0000
12:110626489:AACT:Adonor_gain1.0000
12:110626489:AACTG:Adonor_loss1.0000
12:110626490:ACT:Adonor_gain1.0000
12:110626490:ACTG:Adonor_loss1.0000
12:110626491:CT:Cdonor_gain1.0000
12:110626491:CTG:Cdonor_loss1.0000
12:110626492:TGT:Tdonor_loss1.0000
12:110626493:G:GGdonor_gain1.0000
12:110626493:GT:Gdonor_loss1.0000
12:110626494:T:Gdonor_loss1.0000
12:110626495:AAG:Adonor_loss1.0000
12:110628796:GAA:Gacceptor_gain1.0000
12:110628916:GAGGT:Gdonor_loss1.0000
12:110628917:AGGTG:Adonor_loss1.0000
12:110632470:A:AGacceptor_gain1.0000
12:110632470:AGTAT:Aacceptor_gain1.0000
12:110632471:G:GGacceptor_gain1.0000
12:110632471:GTAT:Gacceptor_gain1.0000

AlphaMissense

3845 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:110632538:T:AC231S0.989
12:110632539:G:CC231S0.989
12:110642355:T:CF433L0.988
12:110642357:T:AF433L0.988
12:110642357:T:GF433L0.988
12:110634696:T:AC247S0.986
12:110634697:G:CC247S0.986
12:110642379:T:AC441S0.986
12:110642380:G:CC441S0.986
12:110647797:T:CF557L0.986
12:110647799:T:AF557L0.986
12:110647799:T:GF557L0.986
12:110634696:T:CC247R0.985
12:110634672:T:CF239L0.983
12:110634674:T:AF239L0.983
12:110634674:T:GF239L0.983
12:110642356:T:GF433C0.983
12:110647792:T:AV555D0.983
12:110632538:T:CC231R0.981
12:110619904:T:AC97S0.979
12:110619905:G:CC97S0.979
12:110626378:T:AC120S0.979
12:110626379:G:CC120S0.979
12:110619893:G:AC93Y0.978
12:110647253:T:AW513R0.978
12:110647253:T:CW513R0.978
12:110619847:T:AC78S0.976
12:110619848:G:CC78S0.976
12:110619874:T:AC87S0.976
12:110619875:G:CC87S0.976

dbSNP variants (sampled 300 via entrez): RS1000015790 (12:110637145 C>T), RS1000026923 (12:110621966 C>G,T), RS1000055727 (12:110615677 T>A), RS1000128821 (12:110617081 G>A), RS1000163701 (12:110621625 A>G), RS1000323487 (12:110615895 C>T), RS1000332607 (12:110635485 G>T), RS1000536602 (12:110627340 T>A,C), RS1000692619 (12:110633723 C>T), RS1000743230 (12:110649028 TTTTC>T,TTTTCTTTC), RS1000806883 (12:110633336 C>T), RS1000990780 (12:110626639 G>A,T), RS1001138081 (12:110615879 A>C,G), RS1001150475 (12:110637360 T>C), RS1001233529 (12:110641257 A>G)

Disease associations

OMIM: gene MIM:609863 | disease phenotypes: MIM:213300, MIM:249000, MIM:614173

GenCC curated gene-disease

DiseaseClassificationInheritance
Joubert syndrome 13StrongAutosomal recessive
Joubert syndromeSupportiveAutosomal recessive
Meckel syndromeSupportiveAutosomal recessive

Mondo (4): Joubert syndrome (MONDO:0018772), Meckel syndrome (MONDO:0018921), Joubert syndrome 13 (MONDO:0013608), Joubert syndrome and related disorders (MONDO:0015369)

Orphanet (3): Isolated Joubert syndrome (Orphanet:475), Meckel syndrome (Orphanet:564), Joubert syndrome and related disorders (Orphanet:140874)

HPO phenotypes

80 total (30 of 80 shown, HPO-id order):

HPOTerm
HP:0000003Multicystic kidney dysplasia
HP:0000007Autosomal recessive inheritance
HP:0000028Cryptorchidism
HP:0000037Male pseudohermaphroditism
HP:0000062Ambiguous genitalia
HP:0000068Urethral atresia
HP:0000073Ureteral duplication
HP:0000175Cleft palate
HP:0000202Orofacial cleft
HP:0000221Furrowed tongue
HP:0000238Hydrocephalus
HP:0000252Microcephaly
HP:0000276Long face
HP:0000293Full cheeks
HP:0000316Hypertelorism
HP:0000340Sloping forehead
HP:0000347Micrognathia
HP:0000358Posteriorly rotated ears
HP:0000369Low-set ears
HP:0000426Prominent nasal bridge
HP:0000457Depressed nasal ridge
HP:0000463Anteverted nares
HP:0000482Microcornea
HP:0000486Strabismus
HP:0000508Ptosis
HP:0000518Cataract
HP:0000528Anophthalmia
HP:0000532Abnormal chorioretinal morphology
HP:0000568Microphthalmia
HP:0000612Iris coloboma

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002783_383Body mass index7.000000e-06
GCST002783_540Body mass index6.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004340body mass index

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases abundance2
Air Pollutantsaffects cotreatment, increases abundance, increases expression2
Arsenicdecreases expression, increases abundance2
Smokedecreases expression, increases abundance, increases expression2
aristolochic acid Idecreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
alpha-pineneincreases abundance, affects cotreatment, increases expression1
sodium arsenatedecreases expression, increases abundance1
nickel sulfateincreases expression1
methacrylaldehydeincreases abundance, affects cotreatment, increases expression1
deguelindecreases expression1
4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamidedecreases expression1
pyrachlostrobindecreases expression1
picoxystrobindecreases expression1
Sunitinibdecreases expression1
Acroleinaffects cotreatment, increases expression, increases abundance1
Antimycin Adecreases expression1
Atrazinedecreases expression1
Benzo(a)pyreneaffects methylation1
Doxorubicindecreases expression1
Leaddecreases expression1
Ozoneaffects cotreatment, increases expression, increases abundance1
Phenobarbitalaffects expression1
Rotenonedecreases expression1
Seleniumaffects cotreatment, decreases expression1
Testosteronedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Tunicamycinincreases expression1

Clinical trials (associated diseases)

3 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT00873678Not specifiedCOMPLETEDAssessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome
NCT01401998Not specifiedRECRUITINGARPKD Database Study
NCT04874909Not specifiedCOMPLETEDClassification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)